tumor-targeting antibody (Enlyton)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nametumor-targeting antibody (Enlyton)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionSPECT contrast agent
TargetsUpdating
Therapy Area/IndicationsAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnlyton
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnlyton
Active IndicationsN/A
Inactive IndicationsAdenocarcinoma

Other Information

ATC CodeN/A
Related LinksN/A